Use of Genetic Testing to Guide the Initiation of Warfarin Therapy

Please note: All assessments are current as of the posting date; however, new evidence that may have been published subsequently is not considered.
Review Date: March 27, 2008
Recommendation: This topic was reviewed by the California Technology Assessment Forum on March 5, 2008. It was recommended that the use of genetic testing to guide initial warfarin dosing does not meet Technology Assessment Criteria 3 through 5 for safety, effectiveness and improvement in health outcomes.
Decision: Does Not Meet CTAF Criteria
Full Assessment: Download (PDF)

Search Assessments

Email Notification

Sign up to receive email notifications of upcoming CTAF meetings and new assessments.

 


Methodology

Learn about CTAF's approach to technology assessment.

Criteria used »
Assessment Process »

Suggest an Assessment

Know of a new device, procedure, or test that CTAF should consider for assessment?

Contact us »
  © 2009 California Technology Assessment Forum. All rights reserved.

Contact Us | Privacy Policy | Terms of Use | Credits